Private Equity
California-based Children's Choice is a dental services provider focused on delivering care to children, infants, adolescents and those with special needs
3 min read · 30 July 2019
Potomac Equity Partners LLC said July 30 that it acquired Laser MD Medspa and SculptMe. Financial terms weren’t announced. Laser MD Medspa is a medical spa services company. SculptMe provides the fat reduction treatment CoolSculpting.
3 min read · 30 July 2019
SightMD, a portfolio company of Chicago Pacific Founders, has acquired Park Avenue Eye Institute, a Manhattan-based ophthalmology practice. No financial terms were disclosed.
3 min read · 29 July 2019
OptioSurgical Inc, an analytics software company that helps hospitals and surgery centers reduce medical device costs, has secured $3.3 million in funding round. Next Frontier Capital led the round.
1 min read · 29 July 2019
Magenta Medical, an Israeli developer of heart failure solutions, has raised an undisclosed amount of funding. New Enterprise Associates led the round.
1 min read · 29 July 2019
Mylan NV is merging with Upjohn, the off-patented branded and generic established medicines business of Pfizer Inc. Pfizer shareholders would own 57 percent of the combined company while Mylan would have 43 percent. Upjohn’s brands include Lipitor, Celebrex and Viagra while Mylan is known for the Epipen.
10 min read · 29 July 2019
Longtime healthcare executive Jim Momtazee is departing KKR more than two decades after joining the global buyout firm, according to people familiar with the matter.
2 min read · 29 July 2019
Ardian has agreed to sell its stake in Ionisos to 3i Infrastructure. No financial terms were disclosed. Ionisos is a French provider of cold sterilization services to the medical, pharmaceutical and cosmetics industries.
3 min read · 26 July 2019
Five Arrows Capital Partners has recapitalized Richmond, Virginia-based Averhealth, a provider of substance use disorder treatment monitoring, care management and related support services. No financial terms were disclosed.
3 min read · 25 July 2019
Sofinnova Partners said July 25 that it has sold Breath Therapeutics to Zambon for up to 500 million euros ($556.9 million), including 140 million euros up front. Breath Therapeutics provides inhalation therapies for severe respiratory diseases.
4 min read · 25 July 2019
